JCRRF (JCR Pharmaceuticals Co) E10: $0.26 (As of Mar. 2026)


JCRRF JCR Pharmaceuticals Co Ltd JCRRF
65 GF Score
Price $3.15
GF Value $5.21
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is JCR Pharmaceuticals Co E10?

JCR Pharmaceuticals Co JCRRF 65 E10 is $0.26 as of Mar. 2026. GuruFocus rates JCRRF with a GF Score™ of 65/100 and a GF Value™ of $5.21 (Possible Value Trap). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

JCR Pharmaceuticals Co's adjusted earnings per share data for the three months ended in Mar. 2026 was $0.022. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.26 for the trailing ten years ended in Mar. 2026.

During the past 12 months, JCR Pharmaceuticals Co's average E10 Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of JCR Pharmaceuticals Co was 32.40% per year. The lowest was 3.80% per year. And the median was 25.50% per year.

As of today (2026-06-30), JCR Pharmaceuticals Co's current stock price is $3.145. JCR Pharmaceuticals Co's E10 for the quarter that ended in Mar. 2026 was $0.26. JCR Pharmaceuticals Co's Shiller PE Ratio of today is 12.10.

During the past 13 years, the highest Shiller PE Ratio of JCR Pharmaceuticals Co was 222.36. The lowest was 12.07. And the median was 77.78.


JCR Pharmaceuticals Co  (OTCPK:JCRRF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

JCR Pharmaceuticals Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=3.145/0.26
=12.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of JCR Pharmaceuticals Co was 222.36. The lowest was 12.07. And the median was 77.78.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


JCR Pharmaceuticals Co E10 Related Terms


JCR Pharmaceuticals Co E10 Historical Data

* Premium members only.

The historical data trend for JCR Pharmaceuticals Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JCR Pharmaceuticals Co E10 Chart

JCR Pharmaceuticals Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.25 0.41 0.33 0.26

JCR Pharmaceuticals Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.25 0.23 0.24 0.26

JCRRF vs LLY, JNJ, ABBV: E10 Comparison

For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JCR Pharmaceuticals Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where JCR Pharmaceuticals Co's Shiller PE Ratio falls into.


JCRRF
65GF Score
JCR Pharmaceuticals Co Ltd JCRRF
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JCR Pharmaceuticals Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, JCR Pharmaceuticals Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.022/112.7000*112.7000
=0.022

Current CPI (Mar. 2026) = 112.7000.

JCR Pharmaceuticals Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.021 98.100 0.024
201609 0.057 98.000 0.066
201612 0.027 98.400 0.031
201703 0.031 98.100 0.036
201706 0.035 98.500 0.040
201709 0.099 98.800 0.113
201712 0.043 99.400 0.049
201803 0.045 99.200 0.051
201806 0.021 99.200 0.024
201809 0.079 99.900 0.089
201812 0.035 99.700 0.040
201903 0.134 99.700 0.151
201906 0.028 99.800 0.032
201909 0.041 100.100 0.046
201912 0.065 100.500 0.073
202003 0.065 100.300 0.073
202006 0.057 99.900 0.064
202009 0.035 99.900 0.039
202012 0.158 99.300 0.179
202103 0.269 99.900 0.303
202106 0.112 99.500 0.127
202109 0.563 100.100 0.634
202112 0.261 100.100 0.294
202203 0.108 101.100 0.120
202206 0.082 101.800 0.091
202209 -0.023 103.100 -0.025
202212 0.155 104.100 0.168
202303 0.012 104.400 0.013
202306 0.091 105.200 0.097
202309 0.196 106.200 0.208
202312 -0.005 106.800 -0.005
202403 0.018 107.200 0.019
202406 0.010 108.200 0.010
202409 -0.050 108.900 -0.052
202412 0.006 110.700 0.006
202503 -0.227 111.100 -0.230
202506 -0.031 111.700 -0.031
202509 0.125 112.000 0.126
202512 0.002 113.000 0.002
202603 0.022 112.700 0.022

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.26 mean?
JCR Pharmaceuticals Co (JCRRF) has a E10 of $0.26 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on JCR Pharmaceuticals Co and its competitors.
Is JCR Pharmaceuticals Co's E10 too high?
JCR Pharmaceuticals Co's current E10 is $0.26. Overall, JCR Pharmaceuticals Co has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JCR Pharmaceuticals Co's E10 compare to LLY and JNJ?
JCR Pharmaceuticals Co's E10 of $0.26 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on JCR Pharmaceuticals Co and its competitors. JCR Pharmaceuticals Co's current E10 is $0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JCR Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, JCR Pharmaceuticals Co (JCRRF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.21, compared to a current price of $3.15 — trading 39.6% below its estimated fair value. The current E10 is $0.26. JCR Pharmaceuticals Co's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For JCR Pharmaceuticals Co (JCRRF), the current E10 is $0.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JCR Pharmaceuticals Co (JCRRF) Overvalued in 2026?

Based on GuruFocus' analysis, JCR Pharmaceuticals Co stock appears to be undervalued. The current stock price of $3.15 is trading 39.6% below its estimated GF Value™ of $5.21. GuruFocus considers JCR Pharmaceuticals Co to be Possible Value Trap.

Key valuation signals for JCRRF:

  • E10: $0.26
  • GF Value™: $5.21 vs. price of $3.15 (39.6% below fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the JCRRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JCR Pharmaceuticals Co Business Description

Other Exchanges 4552:Japan
Address 3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
65GF Score

Get the complete analysis for JCRRF

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.15
Price
$5.21
GF Value